Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Dow
Baxter
McKinsey
Harvard Business School

Last Updated: August 15, 2022

Investigational Drug Information for Sarcosine


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Sarcosine?

Sarcosine is an investigational drug.

There have been 15 clinical trials for Sarcosine. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2012.

The most common disease conditions in clinical trials are Schizophrenia, Psychotic Disorders, and Mental Disorders. The leading clinical trial sponsors are China Medical University Hospital, National Science Council, Taiwan, and University of Aarhus.

There are three hundred and eighty-five US patents protecting this investigational drug and thirty-one international patents.

Recent Clinical Trials for Sarcosine
TitleSponsorPhase
Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive DisorderAll India Institute of Medical Sciences, BhubaneswarPhase 4
Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CTUniversity of AarhusEarly Phase 1
Carbon-11 Labeled Sarcosine in Prostate CancerNational Cancer Institute (NCI)

See all Sarcosine clinical trials

Clinical Trial Summary for Sarcosine

Top disease conditions for Sarcosine
Top clinical trial sponsors for Sarcosine

See all Sarcosine clinical trials

US Patents for Sarcosine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sarcosine See Plans and Pricing Bombesin antagonists with deletion of net-residue at the C-terminus Imperial Chemical Industries PLC (London, GB2) See Plans and Pricing
Sarcosine See Plans and Pricing Anticalculus oral composition Colgate-Palmolive Company (Piscataway, NJ) See Plans and Pricing
Sarcosine See Plans and Pricing Halogenated aminohexanoates and aminobutyrates antimicrobial agents The Procter & Gamble Company (Cincinnati, OH) See Plans and Pricing
Sarcosine See Plans and Pricing Endothelin antagonistic cyclic pentapeptides Banyu Pharmaceutical Co., Ltd. (Tokyo, JP) See Plans and Pricing
Sarcosine See Plans and Pricing Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated immune response The United States of America as represented by the Secretary of (Washington, DC) See Plans and Pricing
Sarcosine See Plans and Pricing Angiotensin II receptor blocking imidazoles E. I. Du Pont de Nemours and Company (Wilmington, DE) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sarcosine

Drugname Country Document Number Estimated Expiration Related US Patent
Sarcosine Australia AU1736688 2007-06-05 See Plans and Pricing
Sarcosine Belgium BE1002286 2007-06-05 See Plans and Pricing
Sarcosine Brazil BR8802720 2007-06-05 See Plans and Pricing
Sarcosine Switzerland CH676239 2007-06-05 See Plans and Pricing
Sarcosine China CN88103413 2007-06-05 See Plans and Pricing
Sarcosine Germany DE3818958 2007-06-05 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Dow
Baxter
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.